Ko-Med Centra Kliniczne Sp. z o.o.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Rheumatoid arthritis2 trials
• Coronary artery disease1 trial
• Endometriosis1 trial
• Stroke1 trial

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Completed4 trials

Lead sponsor

• Amgen1 trial
• Immunemed Inc.1 trial
• Organon LLC1 trial
• Sanofi1 trial

Closed trials

• Completed

  A Phase 2a multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Burfiralimab (hzVSF-v13) added to disease-modifying antirheumatic drugs in patient with moderate to severe Rheumatoid Arthritis

  2023-507944-35-00· Phase 2· Immunemed Inc.· Source

• Completed

  A study to investigate efficacy and safety of OG-6219 twice a day in 3 dose levels compared with Placebo in participants aged 18 to 49 with moderate to severe endometriosis-related pain

  2022-501310-57-00· Phase 2· Organon LLC· Source

• Completed

  A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis

  NCT06073093· Phase 2· Sanofi· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source